TABLE 2.
Summary of simulation results.
Analysis | Incremental | ICER, $/QALY | |||
---|---|---|---|---|---|
Cost, $ | QALYs | Cost, $ | QALYs | ||
Base case analysis | |||||
First-line chemotherapy | 22,943 | 1.63 | |||
First-line LY01008 combined with chemotherapy | 49,182 | 2.11 | 26,240 | 0.48 | 54,430 |
Scenario analysis | |||||
First-line chemotherapy | 22,943 | 1.63 | |||
First-line LY01008 combined with chemotherapy | 38,429 | 2.11 | 15,487 | 0.48 | 32,125 |
QALYs, quality-adjusted life-years; ICER, incremental cost-effectiveness ratio.